心肺运动试验在心力衰竭中的应用:病理生理学与预测标志物
本文综述了心肺运动试验(CPET)在心力衰竭(HF)中的病理生理学基础与预后评估价值。文章指出CPET可可靠评估射血分数保留的心衰(HFpEF)和射血分数降低的心衰(HFrEF)的早期特征及预后,并呼吁在HFpEF早期诊断中更广泛应用CPET。
要点
- CPET通过连续无创测量心血管和呼吸参数评估心衰严重程度与预后。
- CPET是晚期心衰和移植评估的标准检查,应扩大应用于HFpEF早期诊断。
- HFpEF与HFrEF具有相似的患病率和不良结局,但早期表现认识不足。
核心结论
- CPET可评估HFpEF和HFrEF的早期特征及预后,应扩大在HFpEF早期诊断中的应用。
研究设计与样本
- 综述,总结了心衰运动不耐受的病理生理学及CPET的关键发现。
主要发现
- CPET可评估HFpEF和HFrEF的损伤严重程度及预后意义。
临床怎么用
- CPET已用于晚期心衰和移植评估,可考虑用于HFpEF的早期诊断和评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the numerous recent advancements in therapy, heart failure (HF) remains a principle cause of both morbidity and mortality. HF with preserved ejection fraction (HFpEF), a condition that shares the prevalence and adverse outcomes of HF with reduced ejection fraction, remains poorly recognised in its initial manifestations. Cardiopulmonary exercise testing (CPET), defined as a progressive work exercise test that includes non-invasive continuous measurement of cardiovascular and respiratory parameters, provides a reliable mode to evaluate for early features and for the assessment of prognostic features of both forms of HF. While CPET measurements are standard of care for advanced HF and transplant programmes, they merit a broader clinical application in the early diagnosis and assessment of patients with HFpEF. In this review, we provide an overview of the pathophysiology of exercise intolerance in HF and discuss key findings in CPETs used to evaluate both severity of impairment and the prognostic implications.
引用
- Buber, Robertson. Cardiopulmonary exercise testing for heart failure: pathophysiology and predictive markers. Heart. 2023. PMID: 35410893. doi:10.1136/heartjnl-2021-319617
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。